Showing results (41-50 of 297) with videos related to
Sort By:
Pageof 30
Cellular Oncology (Dordrecht, Netherlands)|October 17, 2013
Increase in ezrin expression from benign to malignant breast tumoursDaphne Gschwantler-Kaulich, Camilla Natter, Stefan Steurer, et al.Oncology Reports|July 6, 2007
Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancerAnneliese Fink-Retter, Daphne Gschwantler-Kaulich, Gernot Hudelist, et al.Scientific Reports|February 20, 2021
Decision theory for precision therapy of breast cancerMichael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, et al.Breast Cancer Research and Treatment|September 28, 2007
Differential gene expression profile in breast cancer-derived stromal fibroblastsChristian F Singer, Daphne Gschwantler-Kaulich, Anneliese Fink-Retter, et al.Journal of Cancer Research and Clinical Oncology|September 27, 2005
Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancerWolfgang J Köstler, Gernot Hudelist, Werner Rabitsch, et al.Cancer Investigation|August 25, 2018
Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast CancerSabine Danzinger, Yen Yen Tan, Margaretha Rudas, et al.Oncotarget|November 5, 2017
Gene expression information improves reliability of receptor status in breast cancer patientsMichael Kenn, Karin Schlangen, Dan Cacsire Castillo-Tong, et al.Journal of Personalized Medicine|July 2, 2021
Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian CancerChristine Bekos, Christoph Grimm, Marlene Kranawetter, et al.Plos One|September 18, 2012
BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?Andrea Weghofer, Muy-Kheng Tea, David H Barad, et al.Journal of Personalized Medicine|September 28, 2021
Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 MutationsFlorian Reichl, Daniela Muhr, Katharina Rebhan, et al.Pageof 30